Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for pain from red-back spider envenoming
ACTRN12616000889459Phase 4Completed
- Sponsor
- University of Newcastle
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ketamine in Redback spider envenomation, sponsored by University of Newcastle. Primary endpoint: Clinically significant change in pain severity at 30 minutes. Started Jan 2017; status: completed.
02
Drugs
ketamine
03
Conditions
Redback spider envenomation
Beyond the preview
Go deeper on ACTRN12616000889459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000889459.